Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma.
| Publicado en: | Quality of Life Research Vol. 32; no. 8; pp. 2281 - 2293 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Aug2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=164782796&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 164782796 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09629343 GPQ jtl: Quality of Life Research issn: 09629343 maglogo: N pubinfo: dt: Aug2023 vid: 32 iid: 8 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 164782796 162506441 10.1007/s11136-023-03390-5 164782796 ppf: 2281 ppct: 12 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma. aug: au: Murugappan, Meena N. King-Kallimanis, Bellinda L. Bhatnagar, Vishal Kanapuru, Bindu Farley, Joel F. Seifert, Randall D. Stenehjem, David D. Chen, Ting-Yu Horodniceanu, Erica G. Kluetz, Paul G. affil: Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (U.S. FDA), Silver Spring, MD, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|